About
Resilient Biotics develops microbiome-derived live biotherapeutics that prevent respiratory infectious diseases in both animal and human health by leveraging microbiome genomics and data science.
Explore Resilient Biotics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.